Abstract
The diagnosis of primary central nervous system lymphoma (PCNSL) should always be considered as an emergency because of the therapeutic consequences it implies. In immunocompetent patients, it relies on stereotactic biopsy. Unfortunately, clinical and radiological features may be misleading and delay the diagnostic procedure. The case we report here illustrates the contribution of magnetic resonance spectroscopy in the diagnostic approach of a very atypical PCNSL.
Similar content being viewed by others
References
Baehring JM et al (2003) Neurolymphomatosis. Neuro Oncol 5(2):104–115
Beristain X, Azzarelli B (2002) The neurological masquerade of intravascular lymphomatosis. Arch Neurol 59(3):439–443
Kim DG et al (1996) Primary central nervous system lymphoma: variety of clinical manifestations and survival. Acta Neurochir (Wien) 138(3):280–289
Quinones-Hinojosa A et al (2000) Solitary sciatic nerve lymphoma as an initial manifestation of diffuse neurolymphomatosis. Case report and review of the literature. J Neurosurg 92(1):165–169
Shenkier TN (2005) Unusual variants of primary central nervous system lymphoma. Hematol Oncol Clin North Am 19(4):651–664, vi
Singh A et al (1982) Steroid-induced remissions in CNS lymphoma. Neurology 32(11):1267–1271
Al-Yamany M et al (1999) Spontaneous remission of primary central nervous system lymphoma: report of 3 cases and discussion of pathophysiology. J Neurooncol 42(2):151–159
Kon T et al (2003) A primary CNS lymphoma in spontaneous remission for 3.5 years after initial detection of the lesions by MRI. Brain Tumor Pathol 20(1):27–31
Rubin M et al (1987) Spontaneous temporary remission in primary CNS lymphoma. Can J Neurol Sci 14(2):175–177
DeAngelis LM et al (1990) Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology 40(1):80–86
DeAngelis LM (1990) Primary central nervous system lymphoma imitates multiple sclerosis. J Neurooncol 9(2):177–181
Lucchinetti C et al (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47(6):707–717
Lach B, Atack E, Hylton D (1985) Clinical and pathological analysis of primary lymphomas of the brain: association of tumors with demyelinative leukoencephalopathy. Neuropathology Exp Neurol 44(309)
Murphy JK, O’Brien CJ, Ironside JW (1989) Morphologic and immunophenotypic characterization of primary brain lymphomas using paraffin-embedded tissue. Histopathology 15(5):449–460
Ducreux D et al (2003) Diffusion-weighted imaging and single-voxel MR spectroscopy in a case of malignant cerebral lymphoma. Neuroradiology 45(12):865–868
Moller-Hartmann W et al (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44(5):371–381
Hsu EW, Aiken NR, Blackband SJ (1996) Nuclear magnetic resonance microscopy of single neurons under hypotonic perturbation. Am J Physiol 271(6 Pt 1):C1895–C1900
Nelson SJ et al (2002) In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging 16(4):464–476
Harting I et al (2003) Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy. Neurosci Lett 342(3):163–166
Buhring U et al (2001) MRI features of primary central nervous system lymphomas at presentation. Neurology 57(3):393–396
Kuhlmann T et al (2001) Diagnosis of a multifocal B cell lymphoma with preceding demyelinating central nervous system lesions by single voxel proton MR spectroscopy. J Neurol Neurosurg Psychiatry 70(2):259–262
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taillibert, S., Guillevin, R., Menuel, C. et al. Brain lymphoma: usefulness of the magnetic resonance spectroscopy. J Neurooncol 86, 225–229 (2008). https://doi.org/10.1007/s11060-007-9468-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-007-9468-2